Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) Research & Development: 2010-2025

Historic Research & Development for Geron (GERN) over the last 16 years, with Sep 2025 value amounting to $21.1 million.

  • Geron's Research & Development rose 4.55% to $21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.3 million, marking a year-over-year decrease of 28.18%. This contributed to the annual value of $103.7 million for FY2024, which is 17.04% down from last year.
  • Per Geron's latest filing, its Research & Development stood at $21.1 million for Q3 2025, which was down 3.06% from $21.7 million recorded in Q2 2025.
  • In the past 5 years, Geron's Research & Development ranged from a high of $35.5 million in Q2 2023 and a low of $15.1 million during Q1 2025.
  • Over the past 3 years, Geron's median Research & Development value was $27.2 million (recorded in 2023), while the average stood at $26.1 million.
  • In the last 5 years, Geron's Research & Development spiked by 102.28% in 2021 and then slumped by 48.67% in 2025.
  • Geron's Research & Development (Quarterly) stood at $24.1 million in 2021, then increased by 16.81% to $28.2 million in 2022, then rose by 16.66% to $32.9 million in 2023, then declined by 28.80% to $23.4 million in 2024, then grew by 4.55% to $21.1 million in 2025.
  • Its Research & Development stands at $21.1 million for Q3 2025, versus $21.7 million for Q2 2025 and $15.1 million for Q1 2025.